Tiziana Life Sciences (US) (TLSA)
NASDAQ:TLSA
Want to see TLSA full AI Analyst Report?
Total Valuation
Tiziana Life Sciences has a market cap or net worth of $162.83M. The enterprise value is -$65.27M.
Market Cap$162.83M
Enterprise Value-$65.27M
Share Statistics
Tiziana Life Sciences has 118,851,950 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding118,851,950
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Tiziana Life Sciences’s return on equity (ROE) is -354.44 and return on invested capital (ROIC) is -4189.76%.
Return on Equity (ROE)-354.44
Return on Assets (ROA)-1.60
Return on Invested Capital (ROIC)-4189.76%
Return on Capital Employed (ROCE)-74.42
Revenue Per Employee0.00
Profits Per Employee-2.05M
Employee Count9
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Tiziana Life Sciences is ―. Tiziana Life Sciences’s PEG ratio is -0.11.
PE Ratio―
PS Ratio0.00
PB Ratio1.69K
Price to Fair Value1.69K
Price to FCF-6.85
Price to Operating Cash Flow-9.46
PEG Ratio-0.11
Income Statement
In the last 12 months, Tiziana Life Sciences had revenue of 0.00 and earned -18.43M in profits. Earnings per share was -0.32.
Revenue0.00
Gross Profit-234.00K
Operating Income-21.28M
Pretax Income-18.43M
Net Income-18.43M
EBITDA-21.05M
Earnings Per Share (EPS)-0.32
Cash Flow
In the last 12 months, operating cash flow was -12.85M and capital expenditures -21.00K, giving a free cash flow of -12.87M billion.
Operating Cash Flow-12.85M
Free Cash Flow-12.87M
Free Cash Flow per Share-0.11
Dividends & Yields
Tiziana Life Sciences pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.52
52-Week Price Change-10.00%
50-Day Moving Average1.31
200-Day Moving Average1.63
Relative Strength Index (RSI)47.43
Average Volume (3m)166.53K
Important Dates
Tiziana Life Sciences upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Tiziana Life Sciences as a current ratio of 0.76, with Debt / Equity ratio of 1.21%
Current Ratio0.76
Quick Ratio0.76
Debt to Market Cap<0.01
Net Debt to EBITDA0.17
Interest Coverage Ratio-1.18K
Taxes
In the past 12 months, Tiziana Life Sciences has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Tiziana Life Sciences EV to EBITDA ratio is -4.02, with an EV/FCF ratio of -6.57.
EV to Sales0.00
EV to EBITDA-4.02
EV to Free Cash Flow-6.57
EV to Operating Cash Flow-6.58
Balance Sheet
Tiziana Life Sciences has $4.01M in cash and marketable securities with $456.00K in debt, giving a net cash position of $3.55M billion.
Cash & Marketable Securities$4.01M
Total Debt$456.00K
Net Cash$3.55M
Net Cash Per Share$0.03
Tangible Book Value Per Share<$0.01
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Tiziana Life Sciences is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast-40.11%